Lutetium (177lu) oxodotreotide
Lutathera (lutetium dotatate lu-177) is an unknown pharmaceutical. Lutetium dotatate lu-177 was first approved as Lutathera on 2018-01-26. Lutathera's patent is valid until 2038-07-25 (FDA).
| Trade Name | Lutathera |
|---|---|
| Common Name | Lutetium (177lu) oxodotreotide |
| Indication | |
| Drug Class | Antineoplastic agent |
